A $2.7 trillion industry representing 18% of the economy now knows where it's headed. Losing the individual mandate would have been a worst-case scenario for it. More
-
-
Sponsored By:
-
Sponsored By:
Medical Stocks
The Obamacare Ruling: 5 Investing Scenarios
The Supreme Court's looming decision will surely create winners and losers among health care stocks. Here's an investor's guide to the possible outcomes. More
A Medical-Device Maker That Rules Its Niche
Cooper Companies has great cash flow and does well against giant JNJ. More
3 Managed Care Companies That Could Score From Obamacare, if …
... the High Court upholds the health care reform law in toto. The mandate for all Americans to have coverage would bring in lots of young, healthy new members to these managed care companies. More
Sanofi, Michael J. Fox Foundation to Test Parkinson’s Drug
The Michael J. Fox Foundation will team up with French drugmaker Sanofi to test an experimental treatment for Parkinson's disease. More
Here Comes a Bidding War for Amylin
Approval of its diabetes drug has Big Pharma banging on its door, with Bristol-Myers Squibb already said to have offered $3.5 billion, or $22 per share. More
4 Biotech ETFs for a Healthy Portfolio
The sector is coming back strong, and a diversified ETF is the best way to play it. More
